Advertisements


Dividend Stock Analysis of Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ), together with its subsidiaries, is engaged in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates .....»»

Category: blogSource: dividendgrowthinvestorAug 8th, 2019

Johnson & Johnson"s stock surges after earnings beat, raised dividend

Shares of Johnson & Johnson rose 4.8% in premarket trading Tuesday, after the drug and consumer products company reported first-quarter profit and sales that rose above expectations and boosted its dividend, offsetting a downbeat full-year outl.....»»

Category: topSource: marketwatchApr 14th, 2020

Dividend Investors Should Buy Johnson & Johnson Stock On Pullbacks

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Johnson and Johnson's diversified business model will help JNJ stock weather any pot.....»»

Category: topSource: investorplaceApr 9th, 2020

Why Johnson & Johnson Stock Is Not a Screaming Buy

InvestorPlace - Stock Market News, Stock Advice & Trading Tips For dividend investors looking for a high-quality name, Johnson & Johnson st.....»»

Category: topSource: investorplaceOct 8th, 2019

This is Why Johnson & Johnson (JNJ) is a Great Dividend Stock

Zacks.....»»

Category: topSource: redinewsMay 20th, 2019

This is Why Johnson & Johnson (JNJ) is a Great Dividend Stock

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out. Want .....»»

Category: personnelSource: nytMar 28th, 2019

Johnson & Johnson Vs. Pfizer: Which Big Pharma Giant Is The Better Dividend Stock?

Johnson & Johnson Vs. Pfizer: Which Big Pharma Giant Is The Better Dividend Stock?.....»»

Category: topSource: seekingalphaMar 26th, 2019

Johnson Controls International a Top Socially Responsible Dividend Stock With 3.2% Yield (JCI)

Dividend Channel.....»»

Category: topSource: redinewsDec 14th, 2018

J&J Braces For Q1 Earnings With Bearish Charts And Patent Cliffs In Play

Johnson & Johnson's Q1 earnings report on April 16 is expected to show $2.64 EPS and $21.4 billion in revenues. Technical analysis shows a bearish trend but analysts have a neutral rating with a $171.95 price target and potential 37.15% upside. read more.....»»

Category: blogSource: benzingaApr 15th, 2024

Tesla Stock Still Has Significant Downside, Says GLJ Research"s Gordon Johnson

Gordon Johnson, CEO of GLJ Research, reconfirmed his bearish outlook on Tesla Inc (NASDAQ: TSLA) Monday on CNBC's "Squawk Box." Latest Rat.....»»

Category: blogSource: benzingaMay 24th, 2021

Abbvie (ABBV) Dividend Stock Analysis for 2021

AbbVie Inc. (ABBV) discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company was created in 2013, when Abbott Laboratories split into two companies – Abbvie and Abbott. Abbvie.....»»

Category: blogSource: dividendgrowthinvestorMay 6th, 2021

Could Boeing Take Off In May?

Boeing Co (NYSE: BA) is a stock that could blossom in May, chief market technician at Piper Sandler Craig Johnson said Friday on CNBC's "Trading Nation." read more.....»»

Category: blogSource: benzingaApr 30th, 2021

CEO of COVID-19 vaccine maker sold $10M in stock before company destroyed Johnson & Johnson doses

The CEO of Emergent BioSolutions, the government contractor that destroyed 15 million doses of Johnson & Johnson's COVID-19 vaccine, sold more than $10 million worth of his stock in the company before its share prices plummeted......»»

Category: topSource: foxnewsApr 26th, 2021

Johnson & Johnson says paying, increasing dividend "remains a key priority"

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 20th, 2021

Johnson & Johnson raises quarterly dividend 5% to $1.06 per share

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 20th, 2021

J&J beats profit and sales expectations, boosts dividend; COVID-19 vaccine adds $100 million to sales

Johnson & Johnson reported Tuesday first-qu.....»»

Category: topSource: marketwatchApr 20th, 2021

S&P 500 books record high and Nasdaq rallies 1.1% as stock market reacts to Johnson & Johnson pause, hot CPI report

The S&P 500 finished at a record and technol.....»»

Category: topSource: marketwatchApr 13th, 2021

Tesla stock is soaring on record quarterly deliveries, but the EV maker is "barely growing", stock research chief says

Gordon Johnson, the CEO of GLJ Research, says Tesla's 2% sequential growth is hardly "transformational" amid price cuts and increasing sales. Tesla head .....»»

Category: smallbizSource: nytApr 5th, 2021

Emergent"s stock falls 6.8% after error making J&J"s COVID-19 vaccine

Shares of Emergent BioSolutions Inc. were down 6.8% in premarket trading on Thursday, the day after Johnson & Johnson confirmed that a batch of its COVID-19 vaccines manufactured at an Emergent plant did not meet "quality standards." Th.....»»

Category: topSource: marketwatchApr 1st, 2021

Nestle Dividend Stock Analysis

Nestlé S.A. operates as a food and beverage company. The company operates through Zone Europe, Middle East and North Africa; Zone Americas; Zone Asia, Oceania and sub-Saharan Africa; and Nestlé Waters segments. .....»»

Category: blogSource: dividendgrowthinvestorMar 29th, 2021

Nestle Dividend Stock Analysis

Nestle S.A. (OTCMKTS:NSRGY) (SWX:NESN) operates as a food and beverage company. The company operates through Zone Europe, Middle East .....»»

Category: blogSource: valuewalkMar 25th, 2021